Global Microbiome Therapeutics Market Size & Trends Report Segmented By Product (FMT, Probiotics, Prebiotics, Small Molecules), Application (GI, Oncology, Infections Diseases, Autoimmune Diseases), Delivery (Oral, Injectable, Topical) & Regional Forecasts to 2029

Request Quote Download FREE Sample
Single User

Table of Contents

  • Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2023-2024)
  • Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  • Executive Summary
    • Microbiome Therapeutics Market Snapshot (2023-2029)
    • Segment Overview
    • Regional Snapshot
    • Competitive Insights
  • Growing trend toward personalized medicine
  • Growing demand for probiotics and prebiotics
  • Increasing R&D investments
  • Technological advancements in synthetic biology, metagenomics, and microbiome analysis
  • Restraints
    • Regulatory challenges
    • Safety concerns regarding microbiome therapeutics
    • High R&D costs associated with development of microbiome-based therapies
    • Limited awareness and acceptance of microbiome therapeutics
  • Opportunities
    • Exploring new therapeutic areas
    • Growing partnerships and collaborations
    • Microbiome diagnostics
    • Cosmetic and skin care applications
  • Key Market Trends
    • Microbiome-based cancer immunotherapy
    • Expansion beyond gastrointestinal disorders
  • Unmet Market Needs
  • Industry Speaks
  • Regulatory Analysis
  • Globics Market Size & Forecast (2022-2029), By Product, USD Million
    • Introduction
    • Probiotics
    • Prebiotics
    • Fecal Microbiota Transplantation (FMT)
    • Postbiotics
    • Small Molecules
    • Others
  • Global Microbiome Therapeutics Market Size & Forecast (2022-2029), By Application, USD Million
    • Introduction
    • Gastrointestinal Disorders
    • Oncology
    • Endocrine and Metabolic Disorders
    • Autoimmune Diseases
    • Infectious Diseases
    • Others
  • Global Microbiome Therapeutics Market Size & Forecast (2022-2029), By Mode of Delivery, USD Million
    • Introduction
    • Oral Delivery
    • Injectables
    • Topical
    • Others
  • Global Microbiome Therapeutics Market Size & ForecMillion
    • Introduction
    • North America Microbiome Therapeutics Market Size & Forecast (2022-2029), By Country, USD Million
      • US
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Mode of Delivery (USD Million)
      • Canada
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Mode of Delivery (USD Million)
    • Europe Microbiome Therapeutics Market Size & Forecast (2022-2029), By Country, USD Million
      • UK
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By MSD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Mode of Delivery (USD Million)
      • France
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Mode of Delivery (USD Million)
      • Italy
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Mode of Delivery (USD Million)
      • Spain
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Mode of Delivery (USD Million)
      • Rest of Europe
        • Mararket Size & Forecast, By Mode of Delivery (USD Million)
    • Asia Pacific (APAC) Microbiome Therapeutics Market Size & Forecast (2022-2029), By Country, USD Million
      • China
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Mode of Delivery (USD Million)
      • Japan
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Mode of Delivery (USD Million)
      • India
        • Market Size & Forecast, By Product (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Mode of Delivery (USD Million)
      • Rest oast, By Application (USD Million)
      • Market Size & Forecast, By Mode of Delivery (USD Million)
  • Latin America (LATAM) Microbiome Therapeutics Market Size & Forecast (2022-2029), USD Million
    • Market Size & Forecast, By Product (USD Million)
    • Market Size & Forecast, By Application (USD Million)
    • Market Size & Forecast, By Mode of Delivery (USD Million)
  • Middle East & Africa (MEA) Microbiome Therapeutics Market Size & Forecast (2022-2029), USD Million
    • Market Size & Forecast, By Product (USD Million)
    • Market Size & Forecast, By Application (USD Million)
    • Market Size & Forecast, By Mode of Delivery (USD Million)
  • Competitive Landscape
    • Key Players and their Competitive Positioning
      • Key Player Comparison
      • Segmetegorization Matrix
        • Dominants/Leaders
        • New Entrants
        • Emerging Players
        • Innovative Players
      • Key Strategies Assessment, By Player (2022-2024)
        • New Product Launches
        • Partnerships, Agreements, & Collaborations
        • Mergers & Acquisitions
        • Geographic Expansion
  • Company Profiles*(Business Overview, Financial Performance**, Products Offered, Recent Developments)
    • Seres Therapeutics
    • Ferring Pharmaceuticals
    • BiomeBank
    • Pendulum
    • Seed Health, Inc.
    • Biohm
    • Actial Farmaceutica Srl
    • OptiBiotix Health Plc.
    • ExeGi Pharma
    • Other Prominent Players
  • Note: *Indicative list

    **For liste